Public filings / NRIX on Yahoo Finance (opens in a new tab)
NRIX: who owns it, insider trades, analyst moves
Nurix Therapeutics, Inc.
A summary of public filings about Nurix Therapeutics, Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · dated snapshot
Reported holdings for NRIX
4 rows in loaded coverage. Historical filing values, not current holdings or prices. Related managers may overlap; mappings and share comparisons remain unvalidated. Last successful refresh: 2026-11-11 20:50 ET.
| Reporting manager | Holdings as of | Reported value | Reported-universe weight |
|---|---|---|---|
| Baker Bros. Advisors | 2026-06-30 | $113,016,569 | 0.57% |
| Deep Track Capital | 2026-06-30 | $187,686,398 | 2.76% |
| Perceptive Advisors | 2026-06-30 | $104,813,438 | 1.63% |
| Rubric Capital | 2026-06-30 | $175,345,894 | 1.61% |
SEC Form 4
Recent insider trades in NRIX
| Filed (ET) | Insider | Type | Value | Filing |
|---|---|---|---|---|
| 2026-10-15 17:00 | Hansen Gwenn Chief Scientific Officer | Sale | $36K | SEC |
As of the last site build. The live lookup shows 12 months of Form 4 filings.
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.
